Home Pixelgen Technologies

Pixelgen Technologies

In operation
Series B
Developer of Molecular Pixelation Technology
Basic
Enterprise Profile
LinkedIn

Basic Information

Pixelgen Technologies AB, founded in 2020 by a group of passionate and experienced innovators and entrepreneurs, envisions bringing a new spatial understanding to biology by mapping cell surface proteins and their spatial interrelations. The company has developed Molecular Pixelation, a DNA-based visualization technology used to analyze cell surface proteins for novel insights into cellular activities, driving the development of better drugs and diagnostics. Pixelgen Technologies is pioneering an entirely new approach to spatial proteomics through molecular pixelation.
Pixelgen Technologies AB
Stockholm,Stockholm,Sweden
less than 15 people
January 01, 2020
hello@pixelgen.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Information Technology Vendors # Diagnostic Manufacturing
Technology
Cell Technology
Concept
Tumor Immune System Diseases Hematologic Diseases Laboratory Diagnosis
Application Scenarios
Medical Device Consumables